Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer

被引:1
|
作者
Qiu, Yu [1 ,2 ]
Chen, Yan [1 ,2 ]
Shen, Haoyang [1 ,2 ]
Yan, Shuixin [1 ,2 ]
Li, Jiadi [1 ,2 ]
Wu, Weizhu [1 ,3 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Hlth Sci Ctr, Ningbo 315000, Zhejiang, Peoples R China
[3] Affiliated Lihuili Hosp, 1111 Jiangnan Rd, Ningbo 315000, Zhejiang, Peoples R China
关键词
triple-negative breast cancer; Naples prognostic score; prognostic factor; nomogram predictive model; INFLAMMATION;
D O I
10.2147/JIR.S472917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study investigated the correlation between the Naples prognostic score (NPS), clinicopathological traits, and the postoperative prognoses of patients with triple-negative breast cancer (TNBC). Based on NPS, a predictive nomogram was developed to estimate the long-term survival probabilities of patients with TNBC post-surgery. Patients and Methods: We retrospectively examined the clinical records of 223 women with TNBC treated at Ningbo Medical Center, Lihuili Hospital between January 1, 2016 and December 31, 2020. Blood tests and biochemical analyses were conducted before surgery. The prognostic nutritional index (PNI), controlling nutritional status (CONUT), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and NPS were determined based on blood-related markers. A Kaplan-Meier survival analysis assessed the association between NPS, PNI, CONUT score, overall survival (OS), and breast cancer-specific survival (BCSS). Predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUC) and C index. The patients were randomly divided into the training and the validation group (6:4 ratio). A nomogram prediction model was developed and evaluated using the R Software for Statistical Computing (RMS) package. Results: NPS outperformed other scores in predicting inflammation outcomes. Patients with an elevated NPS had a poorer prognosis (P<0.001). Lymph node ratio (LNR), surgical method, postoperative chemotherapy, and NPS independently predicted OS, whereas M stage, LNR, and NPS independently predicted BCSS outcome. The OS and BCSS predicted by the nomogram model aligned well with the actual OS and BCSS. The decision curve analysis showed significant clinical utility for the nomogram model. Conclusion: In this study, NPS was an important prognostic indicator for patients with TNBC. The nomogram prognostic model based on NPS outperformed other prognostic scores for predicting patient prognosis. The model demonstrated a clear stratification ability for patient prognosis, which emphasized the potential benefits of early intervention for high-risk patients. Plain Language Summary: In this study, we aimed to understand how the Naples prognostic score (NPS) scoring system could predict the prognosis for patients with triple-negative breast cancer (TNBC). TNBC is a type of breast cancer that can be difficult to treat. Medical records of 223 women with TNBC were retrospectively analyzed. These women had their blood tested before surgery to check for certain markers related to nutrition and inflammation. NPS was used along with other scores to determine their accuracy in predicting survival. NPS was better at predicting outcomes than the other scores. The patients with higher NPS scores tended to have poorer outcomes. We also created a visual tool called a nomogram to help doctors predict patient outcomes based on the NPS scores. NPS can be a valuable tool for doctors treating patients with TNBC because it can help them predict how well a patient might do after surgery. This information could be used to tailor treatment plans for these patients. The nomogram provides a user-friendly way for doctors to use NPS in their practice. Overall, this study showed that NPS is a powerful tool for predicting outcomes for patients with TNBC, which could lead to better treatment decisions and improved outcomes for these patients.
引用
收藏
页码:5253 / 5269
页数:17
相关论文
共 50 条
  • [21] Emerging Novel Therapeutics in Triple-Negative Breast Cancer
    Lyons, Tomas G.
    Traina, Tiffany A.
    BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 377 - 399
  • [22] Gene expression in triple-negative breast cancer in relation to survival
    Shuyang Wang
    Alicia Beeghly-Fadiel
    Qiuyin Cai
    Hui Cai
    Xingyi Guo
    Liang Shi
    Jie Wu
    Fei Ye
    Qingchao Qiu
    Ying Zheng
    Wei Zheng
    Ping-Ping Bao
    Xiao-ou Shu
    Breast Cancer Research and Treatment, 2018, 171 : 199 - 207
  • [23] Gene expression in triple-negative breast cancer in relation to survival
    Wang, Shuyang
    Beeghly-Fadiel, Alicia
    Cai, Qiuyin
    Cai, Hui
    Guo, Xingyi
    Shi, Liang
    Wu, Jie
    Ye, Fei
    Qiu, Qingchao
    Zheng, Ying
    Zheng, Wei
    Bao, Ping-Ping
    Shu, Xiao-ou
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 199 - 207
  • [24] The influence of comorbidity on treatment and survival of triple-negative breast cancer
    Parise, Carol A.
    Caggiano, Vincent
    BREAST JOURNAL, 2020, 26 (09) : 1729 - 1735
  • [25] High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
    F Zagouri
    Z Bago-Horvath
    F Rössler
    A Brandstetter
    R Bartsch
    C A Papadimitriou
    C Dimitrakakis
    A Tsigginou
    I Papaspyrou
    A Giannos
    M-A Dimopoulos
    M Filipits
    British Journal of Cancer, 2013, 108 : 1100 - 1105
  • [26] High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
    Zagouri, F.
    Bago-Horvath, Z.
    Roessler, F.
    Brandstetter, A.
    Bartsch, R.
    Papadimitriou, C. A.
    Dimitrakakis, C.
    Tsigginou, A.
    Papaspyrou, I.
    Giannos, A.
    Dimopoulos, M-A
    Filipits, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1100 - 1105
  • [27] Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancer
    Yoshikawa, Katsuhiro
    Ishida, Mitsuaki
    Yanai, Hirotsugu
    Tsuta, Koji
    Sekimoto, Mitsugu
    Sugie, Tomoharu
    ONCOLOGY LETTERS, 2022, 23 (04)
  • [28] Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
    Zakaria, Fatma
    El-Mashad, Nehal
    Mohamed, Dareen
    ALEXANDRIA JOURNAL OF MEDICINE, 2016, 52 (02): : 131 - 140
  • [29] Triple-Negative Breast Cancer: Pattern of Recurrence and Survival Outcomes
    Chintalapani, Shyny Reddy
    Bala, Stalin
    Konatam, Meher Lakshmi
    Gundeti, Sadashivudu
    Kuruva, Siva Prasad
    Hui, Monalisa
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (01) : 67 - 72
  • [30] Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
    Guo, Liying
    Zhu, Qianwen
    Aisimutuola, Mulati
    Yilamu, Dilimina
    Liu, Sha
    Jakulin, Adina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2147 - 2150